Drug intelligence / Profile preview

3,4,5-tricaffeoylquinic acid

Development stage
Unknown
Lead developer
Pyeongtaek St. Mary's Hospital
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

3,4,5-Tricaffeoylquinic acid (3,4,5-triCQA or TCQA) is a naturally occurring polyphenolic caffeoylquinic acid derivative found in various plants, including sweet potato leaves, propolis, and coffee. It exhibits potent antioxidant, anti-inflammatory, neuroprotective, and hair growth-promoting properties. In preclinical models of Parkinson's disease, 3,4,5-triCQA has been shown to inhibit MPP⁺-induced neuronal apoptosis by suppressing mitochondrial membrane depolarization, preventing reactive oxygen species (ROS) accumulation, and maintaining intracellular glutathione (GSH) homeostasis. Additionally, it promotes adult neurogenesis and improves cognitive deficits in aging and Alzheimer's disease models by stimulating neural stem cell differentiation and activating the Wnt/β-catenin signaling pathway. 3,4,5-triCQA also accelerates hair follicle transition from the telogen to the anagen phase and stimulates hair growth through β-catenin activation in dermal papilla cells. It is primarily investigated as a research reagent and nutraceutical candidate for neurodegenerative disorders and alopecia.

Other names
(1S,3R,4S,5R)-3,4,5-tris[(E)-3-(3,4-dihydroxyphenyl)acryloyloxy]-1-hydroxy-cyclohexanecarboxylic acid(3R,5R)-3,4,5-tris[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-1-hydroxycyclohexane-1-carboxylic acid3,4,5-tri-O-caffeoylquinic acid3,4,5-Tri CQA3,4,5-triCQA3,4,5-Tri-CQATCQA
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)CTNNB1 (Beta-catenin)Integrase allosteric pocket (HIV)NF-κBTLR4 (Toll-like receptor 4)TP53 (Cellular Tumor Antigen p53 R175H)Sucrase-Isomaltase

Beyond the preview

Go deeper on 3,4,5-tricaffeoylquinic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3,4,5-tricaffeoylquinic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call